| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225840 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Treating the intact lung with pleural IMRT in patients with malignant pleural mesothelioma is a safe and feasible treatment option with an acceptable rate of pneumonitis. Additionally, the survival rates were encouraging in our retrospective series, particularly for the patients who underwent pleurectomy/decortication. We have initiated a Phase II trial of induction chemotherapy with pemetrexed and cisplatin with or without pleurectomy/decortication, followed by pleural IMRT to prospectively evaluate the toxicity and survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kenneth E. M.D., Marjorie G. M.D., Benjamin M.D., Lee M. M.D., Ellen Ph.D., Camelia S. M.D., Andreas M.D., Raja M.D., Valerie M.D.,